Representative of Pharmaceutical Industries and Medical Supply Sector in Jordan Chamber of Industry (JCI), Fadi Atrash, said the Kingdom is "now among the most advanced" countries in the pharmaceutical and medical supplies industry, as its products see demand at the global level.
اضافة اعلان
In remarks to "Petra" Saturday, Atrash noted the sector enjoys His Majesty King Abdullah II's support and attention, which secured its development and modernization, and attracted investments, adding that its products have become the "focus of global" attention due to their "competitiveness and high quality."
Atrash added that the sector has 151 industrial facilities with a registered capital of JD385 million and employs 10,000 workers (directly and indirectly), 95% of whom are Jordanians, while the rate of female workers reaches 35% of the total figure.
Atrash indicated that these establishments manufacture products that reach the markets of 80 globally.
Over the past years, Atrash stated the sector has witnessed "significant" development and has worked to provide "high-quality" products that are accepted locally and globally, thanks to the innovation and "unrelenting" efforts of its industrial facilities.
Atrash noted the sector possesses "numerous and diverse" products, mainly medical and therapeutic materials, drugs, veterinary therapeutic products, dental supplies, therapeutic preparations, medical disinfectants, laboratory reagents, equipment, nutritional supplements, and vitamins.
The sector, he said, has an "interconnected" relationship with various industries and institutions within the Kingdom's medical sector, particularly hospitals, laboratories, medical analysis centers, specialized centers, the commercial sector, and pharmacies.
Atrash noted the sector's contribution to the gross domestic product amounts to approximately 4% and accounts for 11% of the total current production of manufacturing industries, while 51% of the total production constitutes added value.
Atash indicated that the sector's products have obtained the "necessary" quality certificates and accreditations for export and progress, adding that global access has reflected in developing service industries needed to provide a "distinguished and advanced" national product, particularly in the packaging and engineering industries, energy services, and information technology.
Atrash remarked the sector's facilities have achieved "significant" accomplishments in terms of production, exports, and technological development.
The sector's current production volume has grown "significantly" over the past 25 years, reaching approximately JD1.62 billion annually, he pointed out.
Atrash stated the sector includes three sub-sectors, namely human pharmaceutical industries, veterinary pharmaceuticals, and medical supplies, adding that human pharmaceuticals constitute approximately 85% of the sector's total activity.
Over the past decade, he noted the sector's exports have doubled, reaching JD612 million last year, marking a 15% increase over 2023, adding that Saudi Arabia, Iraq, Algeria, and the United States are the main importers of its products.
Atrash also referred to a "significant" opportunity to increase the sector's growth and exports based on the Economic Modernization Vision and its "essential" pillars to support the sector and increase its contribution to the gross domestic product.
The Kingdom, he said, possesses "numerous" export opportunities to various countries globally in various industrial sectors, mainly the therapeutic industries and medical supplies, which are estimated at more than $515 million to various countries.
